dmt

Home » dmt

Psychedelic Drugs Market 2021 Worth Observing Growth | Global Players – Klarisana, AstraZeneca, F. Hoffmann-La Roche, Dr. Reddy’s Laboratories

The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market.

Entheon Biomedical Announces Ethics Approval for In Vivo DMT Study

Science in Action has confirmed that it has received ethics approval for an in vivo non-GLP toxicology study of N, N Dimethyltryptamine (DMT) (the "Study"). Both Entheon and Science in Action have applied for requisite permits in order to export, receive and research DMT drug product.

By |2021-02-22T23:05:28-08:00February 22, 2021|DMT, Psychedelic News, Studies|0 Comments

Algernon Pharmaceuticals Awards DMT Manufacturing Contract to Dalton Pharma for Stroke Program

N,N-Dimethyltryptamine, or DMT, is a hallucinogenic tryptamine drug producing effects similar to those of other psychedelics like LSD, ketamine, psilocybin and psilocin. DMT occurs naturally in many plant species and animals and has been used in religious ceremonies as a traditional spiritual medicine by indigenous people in the Amazonian basin. DMT can also be synthesised in a laboratory.

By |2021-02-20T01:02:20-08:00February 20, 2021|Articles & News, DMT|0 Comments

California Would Legalize Possession Of Psychedelics Like LSD, DMT And Psilocybin Under New Senate Bill

Possession of psychedelics such as psilocybin mushrooms, LSD and DMT would be legalized in California under a new Senate bill that was introduced on Wednesday.

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

– MindMed (NEO: MMED) (OTCQB: MMEDF) (DE: MMQ), a leading psychedelic medicine biotech company announced a new partnership with Swiss startup MindShift Compounds AG to develop and patent next-gen psychedelic compounds with psychedelic or empathogenic properties.

By |2021-02-11T19:20:25-08:00February 11, 2021|Articles & News, DMT|0 Comments

What Happens To Our Brains When Taking Hallucinogenics Like Ayahuasca?

While some substances like ketamine and LSD have been extensively studied, researchers are now looking at other overlooked psychedelics, including a South American substance called ayahuasca, a potent beverage historically linked to peoples and tribes of the Amazon rainforest.

By |2019-12-01T23:57:46-08:00December 1, 2019|Articles & News, Ayahuasca, DMT, LSD, Magic Mushrooms|0 Comments

What Does DMT Do To Our Brains?

Dimethyltryptamine or DMT is a potent psychedelic drug. Humans have used psychedelic compounds for hundreds, if not thousands, of years. In modern times, psychedelics are most commonly associated with the 1960s when “dropping (lysergic) acid” or taking “magic” psilocybin mushrooms became popular.

By |2019-12-01T23:43:24-08:00December 1, 2019|Articles & News, Ayahuasca, DMT, LSD, Magic Mushrooms|0 Comments

Map Shows Up To 100 Cities Are Thinking About Decriminalizing Psychedelics

The movement to decriminalize psychedelics has spread so rapidly this year that it can be hard to keep track.

By |2019-12-01T22:27:20-08:00December 1, 2019|Articles & News, Ayahuasca, DMT, LSD, Magic Mushrooms, MDMA|0 Comments
Load More Posts
Go to Top